Home | Biography | Cirriculm Vitae | Current Activities | Papers | Contact
William J. Rutter, Ph.D.
Last Updated: March 20, 2007
CURRENT CORPORATE ACTIVITIES
| Synergenics, LLC |
| |
Founder, Chairman, CEO 2003 - Present |
| |
Consortium of biotech startups; providing financial resources, strategic scientific/ business advice, legal and facilities services |
Commercial Stage Biotech Companies
| iMetrikus |
| |
Founder, Chairman, Board Member 1999 – Present |
| |
Automated data capture from any electronic metric device to form an interactive personal health record. Securely shared over the Internet and accessible to individuals, health care providers, payers, and other health care companies (anonymously) via PC, PDA, mobile phone. Emphasis on chronic condition management (i.e. diabetes, asthma etc.) Worldwide markets. |
| ReLia Diagnostic Systems |
| |
Chairman 2001 – Present |
| |
Rapid quantitative immuno analyzer for point of care diagnostics. Worldwide. Markets. |
| Synco-BioPartners |
| |
Founder, Chairman 2000 – Present |
| |
Process Development and small scale manufacturing: Therapeutic proteins/ antibodies/vaccines. |
| Ventria Biosciences |
| |
Founder, Chairman, Board Member 1992 - Present |
| |
High level production of proteins in cereal grains, specialty: orally active human therapeutic proteins. |
| Epitomics |
| |
Board of Directors 2003 – Present |
| |
Proprietary rabbit monoclonal antibodies for diagnostic research and therapeutic markets. |
Developmental Stage Biotech Companies
| Humabs |
| |
Chairman 2004 - Present |
| |
Human monoclonal antibodies isolated from cloned human memory B cells selected for activity against infectious diseases, cancer and certain other debilitating diseases. Two products in development. |
| Picobella |
| |
Chairman 2003 - Present |
| |
Diagnostic and therapeutic products based on the identification and
characterization of all oncogenes/tumor suppressors. |
| Poetic Genetics |
| |
Chairman 2003 - Present |
| |
Gene therapy based on a proprietary integrase which inserts genetic
elements irreversibly into transcriptional active sites on chromosomes. |
| Investigen |
| |
Chairman 2004 - Present |
| |
“Smart DNA” color test: quantitative sensitive, specific, rapid.Operationally simple. |
| Pathologica |
| |
Chairman 2004 - Present |
| |
Identification and control of a subset of Macrophages implicated in the
causation of cancer, and a variety of debilitating diseases (ALS,
Alzheimer’s, etc). |
| BioEnergenix |
| |
Chairman 2006 – Present |
| |
Identifying, validating and developing novel therapeutic strategies for obesity, diabetes and other metabolic diseases. |
| Synamem |
| |
Chairman 2003 - Present |
| |
Facile analysis of functions of biological membranes, using bioactive membranes on chips and beads. |
Home | Biography | Cirriculm Vitae | Current Activities | Papers | Contact